Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United Healthcare Services, Inc. v. Cephalon, Inc. et al
Case Number:
0:16-cv-02563
Court:
Nature of Suit:
Judge:
Firms
- Berens & Miller
- Boies Schiller
- Bowman & Brooke
- Cravath Swaine
- Kirkland & Ellis
- Lathrop GPM
- Zelle LLP
Companies
Sectors & Industries:
-
November 07, 2016
Minn. Right For Provigil Pay-For-Delay Suit, United Says
An alleged pay-for-delay scheme in which Teva Pharmaceuticals Industries Ltd. and others kept a generic version of the sleep disorder drug Provigil off the market belongs in Minnesota because the drugmaker knew it would be ripping off customers in the state, United Healthcare Services Inc. said Friday.
-
October 17, 2016
Provigil Pay-For-Delay Suit Belongs In Pa., Teva Says
Teva Pharmaceuticals Industries Ltd. and one of its subsidiaries on Friday asked a Minnesota federal court to dismiss them from a United Healthcare suit alleging a conspiracy to keep a generic for the sleep disorder drug Provigil off the market through pay-for-delay deals, or move the case to Pennsylvania.
-
July 29, 2016
United Healthcare Sues Cephalon Over Provigil Pay-For-Delay
United Healthcare Services Inc. on Thursday hit Cephalon Inc. with an antitrust suit claiming that the insurer was forced to pay for the brand name sleep disorder drug Provigil because the drugmaker struck illegal deals to delay generics and lied to the U.S. Patent and Trademark Office.